Adial Pharmaceuticals, Inc. ( ADIL) - Key Metrics
ADIL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$11.25 | -$1.38 | -$1.38 |
| 2026Q1 | $0 | -$1.48 | -$1.18 | -$1.18 |
| 2025Q4 | $0 | -$1.80 | -$1.19 | -$1.19 |
| 2025Q3 | $0 | -$2.02 | -$2.07 | -$2.07 |
| 2025Q2 | $0 | -$4.61 | -$4.12 | -$4.12 |
ADIL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.06 |
| 2026Q1 | 0% | -0.30 |
| 2025Q4 | 0% | -0.76 |
| 2025Q3 | 0% | -1.09 |
| 2025Q2 | 0% | -0.42 |
ADIL
Price: $5.45
52 week price:
Earnings Per Share: -4.89 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 498900
Market Capitalization: 10.5 million